BridgeBio Oncology Therapeutics (BBOT) Treasury Shares (2026)

BridgeBio Oncology Therapeutics (BBOT) posted Treasury Shares of $368470.0 for Q1 2026.

BridgeBio Oncology Therapeutics (BBOT) Treasury Shares (2026) Analysis & Trends

BridgeBio Oncology Therapeutics has reported Treasury Shares for 1 years, with the latest figure at $368470.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	BridgeBio Oncology Therapeutics	726.38 Mn	500.67 Mn	-	282,400.00

Download Data